Mandana Kamgar
Medical College of Wisconsin
51 Papers
49 Citations
Mandana Kamgar is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 25 publications. Previous affiliations of Mandana Kamgar include Wayne State University & University of California, Los Angeles.
Chat about Author
Papers
Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia.
Alireza Esteghamati,Alipasha Meysamie,Omid Khalilzadeh,Armin Rashidi,Mehrdad Haghazali,Fereshteh Asgari,Mandana Kamgar,Mohammad Mehdi Gouya,Mehrshad Abbasi +8 more
TL;DR: A strikingly high prevalence of a number of chronic non-communicable diseases and their risk factors among Iranian adults is documented and urgent preventive interventions should be implemented to combat the growing public health problems in Iran.
Secular trends of obesity in Iran between 1999 and 2007: National Surveys of Risk Factors of Non-communicable Diseases.
Alireza Esteghamati,Omid Khalilzadeh,Kazem Mohammad,Alipasha Meysamie,Armin Rashidi,Mandana Kamgar,Mehrshad Abbasi,Fereshteh Asgari,Mehrdad Haghazali +8 more
TL;DR: The present study highlighted the rapid growth of obesity during recent years in Iran and indicates the crucial necessity of primary prevention programs to counteract this undesired condition.
99
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm.
TL;DR: A contemporaneous appraisal of the evolving targeted therapies and ongoing clinical trials that will likely transform the therapeutic paradigm of biliary tract cancers are provided.
65
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
Asfar S. Azmi,Husain Yar Khan,Irfana Muqbil,Amro Aboukameel,Jasper E. Neggers,Jasper E. Neggers,Dirk Daelemans,Amit Mahipal,Gregory Dyson,Mandana Kamgar,Mohammad Najeeb Al-Hallak,Anteneh Tesfaye,Steve Kim,Vinod B. Shidham,Ramzi M. Mohammad,Philip A. Philip +15 more
TL;DR: A preclinical and ongoing clinical study lends support to the use of selinexor–GEM–nab-paclitaxel as an effective therapy for metastatic PDAC.
Total Neoadjuvant Therapy for Operable Pancreatic Cancer
Rebecca Y Kim,Kathleen K. Christians,Mohammed Aldakkak,Callisia N. Clarke,Ben George,Mandana Kamgar,Abdul H. Khan,Naveen M. Kulkarni,William A. Hall,Beth Erickson,Douglas B. Evans,Susan Tsai +11 more
TL;DR: TNT ensures the delivery of intended systemic therapy prior to a complicated operation without decreasing the chance of successful surgery; a window of operability was not lost.
42